Logo image of GLMD

GALMED PHARMACEUTICALS LTD (GLMD) Stock Price, Quote, News and Overview

NASDAQ:GLMD - Nasdaq - IL0011313900 - Common Stock - Currency: USD

1.62  -0.01 (-0.61%)

After market: 1.6293 +0.01 (+0.57%)

GLMD Quote, Performance and Key Statistics

GALMED PHARMACEUTICALS LTD

NASDAQ:GLMD (4/24/2025, 8:13:52 PM)

After market: 1.6293 +0.01 (+0.57%)

1.62

-0.01 (-0.61%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High23.8
52 Week Low1.21
Market Cap3.66M
Shares2.26M
Float2.23M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-07 2025-05-07
IPO03-13 2014-03-13


GLMD short term performance overview.The bars show the price performance of GLMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40

GLMD long term performance overview.The bars show the price performance of GLMD in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of GLMD is 1.62 USD. In the past month the price decreased by -6.9%. In the past year, price decreased by -65.53%.

GALMED PHARMACEUTICALS LTD / GLMD Daily stock chart

GLMD Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 17.82 319.07B
AMGN AMGEN INC 14.12 150.46B
GILD GILEAD SCIENCES INC 13.71 132.33B
VRTX VERTEX PHARMACEUTICALS INC 1698.17 126.60B
REGN REGENERON PHARMACEUTICALS 13.14 65.57B
ARGX ARGENX SE - ADR 322.85 36.67B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 31.56B
BNTX BIONTECH SE-ADR N/A 28.98B
ONC BEIGENE LTD-ADR N/A 27.60B
SMMT SUMMIT THERAPEUTICS INC N/A 27.06B
NTRA NATERA INC N/A 20.88B
BIIB BIOGEN INC 7.26 17.49B

About GLMD

Company Profile

GLMD logo image Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).

Company Info

GALMED PHARMACEUTICALS LTD

16 Tiomkin Street

TEL AVIV-YAFO 6578317 IL

CEO: Allen Baharaff

Employees: 6

Company Website: https://www.galmedpharma.com

Investor Relations: http://galmedpharma.investorroom.com/

Phone: 97236938448

GALMED PHARMACEUTICALS LTD / GLMD FAQ

What is the stock price of GALMED PHARMACEUTICALS LTD today?

The current stock price of GLMD is 1.62 USD. The price decreased by -0.61% in the last trading session.


What is the ticker symbol for GALMED PHARMACEUTICALS LTD stock?

The exchange symbol of GALMED PHARMACEUTICALS LTD is GLMD and it is listed on the Nasdaq exchange.


On which exchange is GLMD stock listed?

GLMD stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for GALMED PHARMACEUTICALS LTD stock?

7 analysts have analysed GLMD and the average price target is 12.24 USD. This implies a price increase of 655.56% is expected in the next year compared to the current price of 1.62. Check the GALMED PHARMACEUTICALS LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is GALMED PHARMACEUTICALS LTD worth?

GALMED PHARMACEUTICALS LTD (GLMD) has a market capitalization of 3.66M USD. This makes GLMD a Nano Cap stock.


How many employees does GALMED PHARMACEUTICALS LTD have?

GALMED PHARMACEUTICALS LTD (GLMD) currently has 6 employees.


What are the support and resistance levels for GALMED PHARMACEUTICALS LTD (GLMD) stock?

GALMED PHARMACEUTICALS LTD (GLMD) has a resistance level at 1.63. Check the full technical report for a detailed analysis of GLMD support and resistance levels.


Should I buy GALMED PHARMACEUTICALS LTD (GLMD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does GALMED PHARMACEUTICALS LTD (GLMD) stock pay dividends?

GLMD does not pay a dividend.


When does GALMED PHARMACEUTICALS LTD (GLMD) report earnings?

GALMED PHARMACEUTICALS LTD (GLMD) will report earnings on 2025-05-07.


What is the Price/Earnings (PE) ratio of GALMED PHARMACEUTICALS LTD (GLMD)?

GALMED PHARMACEUTICALS LTD (GLMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-39.12).


What is the Short Interest ratio of GALMED PHARMACEUTICALS LTD (GLMD) stock?

The outstanding short interest for GALMED PHARMACEUTICALS LTD (GLMD) is 0.33% of its float. Check the ownership tab for more information on the GLMD short interest.


GLMD Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

GLMD Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to GLMD. The financial health of GLMD is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GLMD Financial Highlights

Over the last trailing twelve months GLMD reported a non-GAAP Earnings per Share(EPS) of -39.12. The EPS increased by 68.95% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -40.63%
ROE -46.04%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%88.19%
Sales Q2Q%N/A
EPS 1Y (TTM)68.95%
Revenue 1Y (TTM)N/A

GLMD Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to GLMD. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners3.08%
Ins Owners1.29%
Short Float %0.33%
Short Ratio0.17
Analysts
Analysts82.86
Price Target12.24 (655.56%)
EPS Next Y96.64%
Revenue Next YearN/A